Evaluation of the Antiangiogenic Potential of AQ4N.

Evaluation of the Antiangiogenic Potential of AQ4N. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Evaluation of the Antiangiogenic Potential of AQ4N. Abstract Text:

PURPOSE: A number of cytotoxic chemotherapy agents tested at low concentrations show antiangiogenic properties with limited cytotoxicity, e.g., cyclophosphamide, tirapazamine, and mitoxantrone. AQ4N is a bioreductive alkylaminoanthraquinone that is cytotoxic when reduced to AQ4; hence, it can be used to target hypoxic tumor cells. AQ4N is structurally similar to mitoxantrone and was evaluated for antiangiogenic properties without the need for bioreduction. EXPERIMENTAL DESIGN: The effect of AQ4N and fumagillin on human microvascular endothelial cells (HMEC-1) was measured using a variety of in vitro assays, i.e., 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, wound scrape, tubule formation, rat aortic ring, and invasion assays. Low-dose AQ4N (20 mg/kg) was also given in vivo to mice bearing a tumor in a dorsal skin flap. RESULTS: AQ4N (10(-11) to 10(-5) mol/L) had no effect on HMEC-1 viability. AQ4N (10(-9) to 10(-5)mol/L) caused a sigmoidal dose-dependent inhibition of endothelial cell migration in the wound scrape model. Fumagillin showed a similar response over a lower dose range (10(-13) to 10(-9) mol/L); however, the maximal inhibition was less (25% versus 43% for AQ4N). AQ4N inhibited HMEC-1 cell contacts on Matrigel (10(-8) to 10(-5) mol/L), HMEC-1 cell invasion, and sprouting in rat aorta explants. Immunofluorescence staining with tubulin, vimentim, dynein, and phalloidin revealed that AQ4N caused disruption to the cell cytoskeleton. When AQ4N (20 mg/kg) was given in vivo for 5 days, microvessels disappeared in LNCaP tumors grown in a dorsal skin flap. CONCLUSIONS: This combination of assays has shown that AQ4N possesses antiangiogenic effects in normoxic conditions, which could potentially contribute to antitumor activity.

Evaluation of the Antiangiogenic Potential of AQ4N. Publishing Authors By Initials

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Evaluation of the Antiangiogenic Potential of AQ4N. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Clinical cancer research : an official journal of

VOLUME: 14

Page Numbers: 1502-9

Journal Abbreviation: Clin. Cancer Res.

ISSN: 1078-0432

DAY: 1

MONTH: Mar

YEAR: 2008

Evaluation of the Antiangiogenic Potential of AQ4N. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9502500

Evaluation of the Antiangiogenic Potential of AQ4N. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Evaluation of the Antiangiogenic Potential of AQ4N. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Evaluation of the Antiangiogenic Potential of AQ4N.

AFFILIATION: Authors' Affiliations: Biomedical Sciences Research Institute, University of Ulster, Coleraine, Northern Ireland, United Kingdom and School of Pharmacy, Queens University of Belfast, Medical Biology Center, Belfast, Northern Ireland, United Kingdom.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Clin Cancer Res

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Evaluation of the Antiangiogenic Potential of AQ4N Related Publications

• "Extra-ordinary" ergonomics: how to accommodate small and big persons, the disabled and elderly, expectant mothers, and children.
• A Framework for Group Analysis of fMRI Data using Dynamic Bayesian Networks.
• A double-switch system regulates male courtship behavior in male and female Drosophila melanogaster.
• A guide to human factors and ergonomics.
• American medical services.
• An attempted suicide when hypoglycaemic.
• An examination of the work of local-authority child-welfare clinics.
• Arterial pressure in an industrial population; and its bearing on the problem of essential hypertension.
• Bayesian network modeling for discovering "dependent synergies" among muscles in reaching movements.
• Cardiovascular disease risk profiles among 'healthy' siblings of patients with early-onset cardiovascular disease: application of the new SCORE system.
• Characterizing task-related temporal dynamics of spatial activation distributions in fMRI BOLD signals.
• Dynamic Bayesian network modeling of fMRI: A comparison of group-analysis methods.
• Effect of induction agent on vasopressor and steroid use, and outcome in patients with septic shock.
• Evaluation of the Antiangiogenic Potential of AQ4N.
• Fetal distress: lessons of the fetal electrocardio-gram.
• Frequency Dependence in a Liquid's Complex Refractive Index Measured with Infrared Spectroradiometry.
• Getting a second opinion: health information and the Internet.
• Hidden Markov Multivariate Autoregressive (HMM-mAR) Modeling Framework for Surface Electromyography (sEMG) Data.
• Invariant SPHARM Shape Descriptors for Complex Geometry in MR Region of Interest Analysis.
• Joint spatial denoising and active region of interest delineation in functional magnetic resonance imaging.
• Laryngoscopic views during rapid sequence intubation in the emergency department.
• MSI-H 'medullary type' adenocarcinoma complicating ileal Crohn's disease; further molecular insight into Crohn's-related carcinogenesis.
• Mental health advocacy with black and minority ethnic communities: conceptual and ethical implications.
• Oat-cell carcinoma of the oesophagus.
• Poverty, race and crime.
• Sarcoidosis involving the heart; report of case with sudden death.
• Social medicine in the universities.
• Spectral Clustering of fMRI Data within Regions of Interest: Clarification of L-dopa effects in Parkinson's Disease.
• The utilization of medical resources.
• Use of the McGrath videolaryngoscope in the management of difficult and failed tracheal intubation.